Stay updated with breaking news from Robert flamm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
All patients treated with INB-200, in clinical development for the treatment of glioblastoma multiforme , have shown a well-tolerated safety profile and longer than anticipated progression free. | March 17, 2022 ....
OXFORD, United Kingdom, March 07, 2022 (GLOBE NEWSWIRE) Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced ....
BOSTON, Feb. 17, 2022 Yumanity Therapeutics , a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for. | February 17, 2022 ....